PubMed=20198447; DOI=10.1007/s11626-010-9298-y
Bradley C.K., Chami O., Peura T.T., Bosman A.G., Dumevska B., Schmidt U., Stojanov T.
Derivation of three new human embryonic stem cell lines.
In Vitro Cell. Dev. Biol. Anim. 46:294-299(2010)

PubMed=20428235; DOI=10.1371/journal.pone.0010263; PMCID=PMC2859053
Hovatta O., Jaconi Devaud M.E.E., Tohonen V., Sloan-Bena F., Gimelli S., Bosman A.G., Holm F., Wyder S., Zdobnov E.M., Irion O., Andrews P.W., Antonarakis S.E., Zucchelli M., Kere J., Feki A.
A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.
PLoS ONE 5:e10263.1-e10263.10(2010)

PubMed=25316320; DOI=10.1021/pr500649m
McQuade L.R., Balachandran A., Scott H.A., Khaira S., Baker M.S., Schmidt U.
Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.
J. Proteome Res. 13:5648-5659(2014)

PubMed=27217344; DOI=10.5966/sctm.2015-0224; PMCID=PMC4996435
Caron L., Kher D., Lee K.L., McKernan R., Dumevska B., Hidalgo A., Li J., Yang H.H., Main H., Ferri G., Petek L.M., Poellinger L., Miller D.G., Gabellini D., Schmidt U.
A human pluripotent stem cell model of facioscapulohumeral muscular dystrophy-affected skeletal muscles.
Stem Cells Transl. Med. 5:1145-1161(2016)

PubMed=27345802; DOI=10.1016/j.scr.2015.10.002
Dumevska B., Bosman A.G., McKernan R., Goel D., Peura T.T., Schmidt U.
Derivation of Genea002 human embryonic stem cell line.
Stem Cell Res. 16:155-158(2016)

PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative p53 mutations.
Nature 545:229-233(2017)